Plasma and Intracellular Concentrations of Raltegravir and Etravirine Administered Once Daily
Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
Hypothesis: the intracellular concentrations of raltegravir (RAL) and etravirine (ETV)
administrated as 800 and 400 mg once a day, respectively, are similar to those obtained with
the standard doses of 400 and 200 mg/12h, respectively.
Objective: To analyze the plasma and intracellular concentrations of RAL and ETV
administrated as 800 and 400 mg once daily respectively compared with standard doses of 400
and 200 mg/12h, respectively, and if they support its once daily administration.